Trump threatens 100% tariff on branded pharmaceutical imports
US President Donald Trump has announced a new tariff of 100% on branded pharmaceutical imports from companies that are not building manufacturing plants in the US.
On his social media platform Truth Social, President Trump said beginning 1 October, the US will levy a 100% tariff on “any branded or patented pharmaceutical unless a company is building their pharmaceutical plant in America”.
He defined building a plant as “breaking ground and/or under construction”.
In August, the Trump Administration imposed a 15% tariff on most pharmaceutical exports from the European Union.
A European pharmaceutical industry group warned that tariffs on medicines “would create the worst of all worlds”.
“Tariffs increase costs, disrupt supply chains and prevent patients from getting life saving treatments,” Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations, said in a statement.
Ireland is one of the biggest exporters of pharmaceutical products to the US from the EU, accounting for €33bn of €120bn of pharmaceutical exports to the US last year.
President Trump also announced a 50% tariff on kitchen cabinets and bathroom vanity units, which he said were “flooding into the country”, and had to be controlled for “national security” and other reasons to protect the US manufacturing base.
Similar reasons were cited for imposing a 25% tariff on heavy trucks imported into the US market.
Article Source – Trump threatens 100% tariff on branded pharmaceutical imports